Zevra Therapeutics, Inc.
ZVRA
$8.31
$0.374.66%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 69.50M | 89.38M | 49.26M | 52.72M | 67.74M |
Total Receivables | 10.51M | 7.79M | 8.95M | 8.31M | 17.38M |
Inventory | 1.97M | -- | -- | -- | -- |
Prepaid Expenses | 4.05M | 2.28M | 2.69M | 1.87M | 1.82M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 86.03M | 99.44M | 60.89M | 62.89M | 86.94M |
|
|||||
Total Current Assets | 86.03M | 99.44M | 60.89M | 62.89M | 86.94M |
Net Property, Plant & Equipment | 1.01M | 1.43M | 1.59M | 1.78M | 1.53M |
Long-term Investments | 4.70M | 4.70M | 4.70M | 4.70M | 4.70M |
Goodwill | 4.70M | 4.70M | 4.70M | 4.70M | 4.70M |
Total Other Intangibles | 68.99M | 70.61M | 66.15M | 67.70M | 69.23M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 11.38M | 9.27M | 11.07M | 14.21M | 9.94M |
Total Assets | 178.13M | 191.55M | 144.41M | 151.28M | 172.33M |
|
|||||
Total Accounts Payable | 13.08M | 24.46M | 20.45M | 22.79M | 13.99M |
Total Accrued Expenses | 17.37M | 8.55M | 6.77M | 4.45M | 18.97M |
Short-term Debt | -- | -- | -- | -- | 37.70M |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 420.00K | 540.00K | 596.00K | 583.00K | 543.00K |
Total Finance Division Other Current Liabilities | 3.20M | 930.00K | 2.63M | 2.09M | 2.52M |
Total Other Current Liabilities | 3.20M | 930.00K | 2.63M | 2.09M | 2.52M |
Total Current Liabilities | 34.07M | 34.48M | 30.45M | 29.91M | 73.72M |
|
|||||
Total Current Liabilities | 34.07M | 34.48M | 30.45M | 29.91M | 73.72M |
Long-Term Debt | 59.50M | 58.90M | 58.33M | 43.00M | 5.07M |
Short-term Debt | -- | -- | -- | -- | 37.70M |
Capital Leases | 372.00K | 483.00K | 544.00K | 705.00K | 456.00K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 44.52M | 27.91M | 22.61M | 28.85M | 31.22M |
Total Liabilities | 138.46M | 121.78M | 111.93M | 102.47M | 110.46M |
|
|||||
Common Stock & APIC | 555.31M | 550.42M | 479.37M | 476.06M | 472.67M |
Retained Earnings | -505.29M | -469.55M | -436.33M | -416.40M | -399.78M |
Treasury Stock & Other | -10.35M | -11.10M | -10.56M | -10.84M | -11.03M |
Total Common Equity | 39.67M | 69.77M | 32.48M | 48.82M | 61.86M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 39.67M | 69.77M | 32.48M | 48.82M | 61.86M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 39.67M | 69.77M | 32.48M | 48.82M | 61.86M |
|